Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by FredTheVoiceon Sep 06, 2019 11:49am

124 Views

Post# 30102535

RE:Weekly Sales Update

SPCEO,

Thanks for the update. Have a great weekend.

I know recently, critics have been hard on your "optimistic" position for TH/THERF regarding the drastic drop in the share price.

But I want to let you know that I bought more on the way down, and my deception is real on the short term with the reaction of the share price, but my general confidence for the near future of this company is still very good.

And a great part of that is me sticking with the facts, and the milestones to come, but another part, is the heart, truth, and energy you put to bring us back to facts about the company and stock market.

It helped me, and I thank you.

Have a great weekend.

FTV.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta